# Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke

Study · id `cardio:ct-nct01758536` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01758536](<https://clinicaltrials.gov/study/NCT01758536>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01758536

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1100 participants.

## Technical summary

Registry record NCT01758536. Randomized; quadruple masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1100 participants (planned count; ClinicalTrials.gov record NCT01758536, source copy `cardio:ctgov-nct01758536-2013-01-23`, retrieved 2026-10-26)
- Start date: 2012-12 (registry gives no type) (ClinicalTrials.gov record NCT01758536, source copy `cardio:ctgov-nct01758536-2013-01-23`, retrieved 2026-10-26)
- Primary completion: 2014-12 (anticipated) (ClinicalTrials.gov record NCT01758536, source copy `cardio:ctgov-nct01758536-2013-01-23`, retrieved 2026-10-26)
- Completion: 2014-12 (anticipated) (ClinicalTrials.gov record NCT01758536, source copy `cardio:ctgov-nct01758536-2013-01-23`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01758536, source copy `cardio:ctgov-nct01758536-2013-01-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01758536-2013-01-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke
- Acronym: HTZZP-INF
- Condition: Ischemic Stroke
- Intervention (Drug): Huatuo Zaizao Pills
- Lead sponsor: Huashan Hospital
- Lead sponsor class: OTHER
- Collaborator: Guangzhou Baiyunshan Qixing Pharmarceutical Co Ltd
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Huashan Hospital (`cardio:org-huashan-hospital`)

## Provenance

Content hash: 38cf533c36aba744a8f3175e76c9a1b53c00f2300850895549dffff44eeeb469
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
